[HTML][HTML] Mortality impact, risks, and benefits of general population screening for ovarian cancer: the UKCTOCS randomised controlled trial.
U Menon, A Gentry-Maharaj, M Burnell… - Health Technology …, 2023 - ncbi.nlm.nih.gov
Mortality impact, risks, and benefits of general population screening for ovarian cancer: the
UKCTOCS randomised controlled trial. - PMC Back to Top Skip to main content NIH NLM Logo …
UKCTOCS randomised controlled trial. - PMC Back to Top Skip to main content NIH NLM Logo …
Ovarian cancer population screening and mortality after long-term follow-up in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised …
U Menon, A Gentry-Maharaj, M Burnell, N Singh… - The Lancet, 2021 - thelancet.com
Background Ovarian cancer continues to have a poor prognosis with the majority of women
diagnosed with advanced disease. Therefore, we undertook the UK Collaborative Trial of …
diagnosed with advanced disease. Therefore, we undertook the UK Collaborative Trial of …
[HTML][HTML] Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial
Background Ovarian cancer has a poor prognosis, with just 40% of patients surviving 5
years. We designed this trial to establish the effect of early detection by screening on ovarian …
years. We designed this trial to establish the effect of early detection by screening on ovarian …
Ovarian cancer screening in the general population: current status
There has been considerable interest in the prospect of early detection of ovarian cancer
through screening asymptomatic women from the general population. The results of recently …
through screening asymptomatic women from the general population. The results of recently …
Ovarian cancer screening effectiveness: A realization from the UK Collaborative Trial of Ovarian Cancer Screening
EJ Pavlik - Women's Health, 2016 - journals.sagepub.com
Effects on survival in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
was reported in The Lancet, and demonstrate that reductions in disease-specific mortality in …
was reported in The Lancet, and demonstrate that reductions in disease-specific mortality in …
Ovarian cancer screening with the Risk of Ovarian Cancer Algorithm (ROCA): Good, bad, or just expensive?
RW Naumann, J Brown - Gynecologic oncology, 2018 - Elsevier
Objectives To measure the effectiveness of ovarian cancer screening using the Risk of
Ovarian Cancer Algorithm (ROCA). Methods A Markov model was constructed based on the …
Ovarian Cancer Algorithm (ROCA). Methods A Markov model was constructed based on the …
Can ovarian cancer screening save lives? The question remains unanswered
Many groups have been working on developing screening strategies for ovarian cancer
since the discovery of CA 1251 and the development of ovarian ultrasonography in the …
since the discovery of CA 1251 and the development of ovarian ultrasonography in the …
Screening for ovarian cancer: a pilot randomised controlled trial
Background The value of screening for ovarian cancer is uncertain. We did a pilot
randomised trial to assess multimodal screening with sequential CA 125 antigen and …
randomised trial to assess multimodal screening with sequential CA 125 antigen and …
The cost-effectiveness of screening for ovarian cancer: results from the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS)
Background: To assess the within-trial cost-effectiveness of an NHS ovarian cancer
screening (OCS) programme using data from UKCTOCS and extrapolate results based on …
screening (OCS) programme using data from UKCTOCS and extrapolate results based on …
The UKCTOCS experience—reasons for hope?
There has been concern about current ovarian cancer screening strategies after the
publication showing a lack of benefit from screening in the ovarian part of the Prostate, Lung …
publication showing a lack of benefit from screening in the ovarian part of the Prostate, Lung …